NLRP3 and esophageal squamous cell carcinoma: Furthermore, research has shown that Fn activates NLRP3 in ESCC cells (esophageal squamous cell carcinoma), which increases MDSCs and significantly reduces the therapeutic efficacy of cisplatin chemotherapy [139].